| Id |
Subject |
Object |
Predicate |
Lexical cue |
| 16609016-0#0#21#gene6143 |
265-669 |
gene6143 |
denotes |
RPL19) to be overexpressed in the malignant cells. Northern blot hybridization analysis done on a wide range of human cell lines and tissues confirmed the level of RPL19 mRNA to be 5-fold higher in malignant cell lines and 8-fold higher in malignant tissues, when compared with their benign counterparts. Analysis of RPL19 mRNA expression by in situ hybridization revealed a significant increase of RPL19 |
| 16609016-0#55#70#diseaseC0376358 |
1399-1512 |
diseaseC0376358 |
denotes |
predictive of shorter patient survival (P < 0.05), revealing RPL19 to be a sensitive predictor of prostate cancer |
| 16609016-0#55#70#diseaseC0600139 |
1399-1512 |
diseaseC0600139 |
denotes |
predictive of shorter patient survival (P < 0.05), revealing RPL19 to be a sensitive predictor of prostate cancer |
| 0#21#gene614355#70#diseaseC0376358 |
16609016-0#0#21#gene6143 |
16609016-0#55#70#diseaseC0376358 |
associated_with |
"RPL19) to be overexpressed in the malignant cells. Northern blot hybridization analysis done on a wide range of human cell lines and tissues confirmed the level of RPL19 mRNA to be 5-fold higher in malignant cell lines and 8-fold higher in malignant tissues, when compared with their benign counterparts. Analysis of RPL19 mRNA expression by in situ hybridization revealed a significant increase of RPL19","predictive of shorter patient survival (P < 0.05), revealing RPL19 to be a sensitive predictor of prostate cancer" |
| 0#21#gene614355#70#diseaseC0600139 |
16609016-0#0#21#gene6143 |
16609016-0#55#70#diseaseC0600139 |
associated_with |
"RPL19) to be overexpressed in the malignant cells. Northern blot hybridization analysis done on a wide range of human cell lines and tissues confirmed the level of RPL19 mRNA to be 5-fold higher in malignant cell lines and 8-fold higher in malignant tissues, when compared with their benign counterparts. Analysis of RPL19 mRNA expression by in situ hybridization revealed a significant increase of RPL19","predictive of shorter patient survival (P < 0.05), revealing RPL19 to be a sensitive predictor of prostate cancer" |
